European Companies Search Engine
UK funding (£580,335): Digital Design of Drug Products Ukri 1 Jun 2014 UK Research and Innovation, United Kingdom
Overview
Text
Digital Design of Drug Products
| Abstract | This project brings together experts in drug development, product formulation, process design, systems modelling and manufacture to create a completely new approach to the design and manufacture of formulated drug products, which involves the integration of qualitative tools for process understanding with a range of in-silico models which describe and predict processing and product performance. It is anticipated that successful outcomes of digital design of drug formulations as envisaged in this proposal via the creation of “Design Space Explorer” will provide unparalleled improvements in reliability, quality and manufacturing processes of pharmaceutical products leading to greater trust by regulatory agencies and by society. Furthermore it is anticipated that a successful outcome to the proposed project has potential to significantly decrease the costs and times associated with the development of new medicines whilst also reducing, refining and and at times removing the need for some clinical studies in patients and healthy volunteers. |
| Category | Collaborative R&D |
| Reference | 101720 |
| Status | Closed |
| Funded period start | 01/06/2014 |
| Funded period end | 31/05/2016 |
| Funded value | £580,335.00 |
| Source | https://gtr.ukri.org/projects?ref=101720 |
Participating Organisations
| SIEMENS PROCESS SYSTEMS ENGINEERING LIMITED |
£443,597.00 |
| GLAXOSMITHKLINE SERVICES UNLIMITED |
£30,204.00 |
| BRITEST LIMITED |
£75,298.00 |
| ASTRAZENECA UK LIMITED |
£31,236.00 |
| PFIZER LIMITED |
The filing refers to a past date, and does not necessarily reflect the current state. The latest known state is available on the following page: Siemens Process Systems Engineering Ltd., Farnborough.
